TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
J T Terapeutikum AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
68
|
53
|
98 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
17
|
2
|
37 |
| EBITDA |
16
|
2
|
37 |
| Total assets |
40
|
51
|
70 |
| Current assets |
40
|
51
|
70 |
| Current liabilities |
8
|
15
|
13 |
| Equity capital |
31
|
36
|
57 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.5%
|
70.6%
|
81.4% |
| Turnover per employee |
34
|
26
|
49 |
| Profit as a percentage of turnover |
25.0%
|
3.8%
|
37.8% |
| Return on assets (ROA) |
42.5%
|
3.9%
|
52.9% |
| Current ratio |
500%
|
340.0%
|
538.5% |
| Return on equity (ROE) |
54.8%
|
5.6%
|
64.9% |
| Change turnover |
16
|
-44
|
5 |
| Change turnover % |
31%
|
-45%
|
6% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.